• 제목/요약/키워드: Secondary cancer

검색결과 477건 처리시간 0.024초

Knowledge, Attitude, and Practice Regarding Cervical Cancer among Rural Community Women in Northeast Thailand

  • Mongsawaeng, Cholticha;Kokorn, Nawaporn;Kujapun, Jirawoot;Norkaew, Jun;Kootanavanichpong, Nusorn;Chavenkun, Wasugree;Ponphimai, Sukanya;Kaewpitoon, Soraya J;Tongtawee, Taweesak;Padchasuwan, Natnapa;Pengsaa, Prasit;Kompor, Pontip;Kaewpitoon, Natthawut
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제17권1호
    • /
    • pp.85-88
    • /
    • 2016
  • Background: Cervical cancer is the second most common malignancy among women worldwide, and women of reproductive age in Thailand. However, information on the behavior regarding cervical cancer in rural community Thailand is sparse. Objective: To assess the knowledge, attitude, and practice regarding cervical cancer (CC) among rural community women in Nakhon Ratchasima, Thailand, using predesigned structured questionnaires. Materials and Methods: A cross-sectional survey was conducted in 8 villages of Non Sung district, Nakhon Ratchasima province, Thailand, during January to April 2015. Bloom's taxonomy was used as a framework for the study. 265 women aged between 30-60 years old were selected by simple random sampling. All participants completed predesigned questionnaires with 4 parts: demographic data, knowledge, attitude, and practice regarding cervical cancer. Descriptive statistics were used for analysis in this study. Results: The majority of participants were in the age group of 41-50 years old (42.6%) with senior secondary school level of education (32.1%), marriage status (85.0%), agricultural employment (59.6%), and family income between 6,000-10,000 baht per month (54.3%). Some 63.4% and 68.7% participants had high knowledge and moderate level of attitudes regarding CC, while 41.1%, 48.7%, and 10.2% had neem regularly, irregularly or never screened for CC, respectively. The main reasons for not screening were were shyness (44.4%) and no time (55.6%). Vaginal discharge and itching were the common signs and symptoms of participants who were screened at a health promotion hospital of sub-district. Conclusions: CC is still a health problem in the rural community. Therefore, health education is required, particularly for those who have never undergone screening.

A Randomized Controlled Trial Comparing Clinical Outcomes and Toxicity of Lobaplatin- Versus Cisplatin-Based Concurrent Chemotherapy Plus Radiotherapy and High-Dose-Rate Brachytherapy for FIGO Stage II and III Cervical Cancer

  • Wang, Ji-Quan;Wang, Tao;Shi, Fan;Yang, Yun-Yi;Su, Jin;Chai, Yan-Lan;Liu, Zi
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권14호
    • /
    • pp.5957-5961
    • /
    • 2015
  • Background: We designed this randomized controlled trial (RCT) to assess whether lobaplatin-based concurrent chemotherapy might be superior to cisplatin-based concurrent chemotherapy for FIGO stage II and III cervical cancer in terms of efficacy and safety. Materials and Methods: This prospective, open-label RCT aims to enroll 180 patients with FIGO stage II and III cervical cancer, randomly allocated to one of the three treatment groups (cisplatin $15mg/m^2$, cisplatin $20mg/m^2$ and lobaplatin $35mg/m^2$), with 60 patients in each group. All patients will receive external beam irradiation (EBRT) and high-dose-rate intracavitary brachytherapy (HDR-ICBT). Patients in cisplatin $15mg/m^2$ and $20mg/m^2$ groups will be administered four cycles of $15mg/m^2$ or $20mg/m^2$ cisplatin intravenously once weekly from the second week to the fifth week during EBRT, while patients inthe lobaplatin $35mg/m^2$ group will be administered two cycles of $35mg/m^2$ lobaplatin intravenously in the second and fifth week respectively during pelvic EBRT. All participants will be followed up for at least 12 months. Complete remission rate and progression-free survival (PFS) will be the primary endpoints. Overall survival (OS), incidence of adverse events (AEs), and quality of life will be the secondary endpoints. Results: Between March 2013 and March 2014, a total of 61 patients with FIGO stage II and III cervical cancer were randomly assigned to cisplatin $15mg/m^2$ group (n=21), cisplatin $20mg/m^2$ group (n=21) and lobaplatin $35mg/m^2$ group (n=19). We conducted a preliminary analysis of the results. Similar rates of complete remission and grades 3-4 gastrointestinal reactions were observed for the three treatment groups (P=0.801 and 0.793, respectively). Grade 3-4 hematologic toxicity was more frequent in the lobaplatin group than the cisplatin group. Conclusions: This proposed study will be the first RCT to evaluate whether lobaplatin-based chemoraiotherapy will have beneficial effects, compared with cisplatin-based chemoradiotherapy, on complete remission rate, PFS, OS, AEs and quality of life for FIGO stage II and III cervical cancer.

암환자의 고통 측정도구 개발에 관한 연구 (Development of a Tool to Measure Suffering in Patients with Cancer)

  • 강경아
    • 대한간호학회지
    • /
    • 제29권6호
    • /
    • pp.1365-1378
    • /
    • 1999
  • This study is a methodological research study to develop an instrument to measure in patients with cancer and to test the validity and reliability of the instrument. The research procedure was as follows : 1) The first step was to develop conceptual framework based on a comprehensive review of the literature and in-depth interviews with patients with cancer. This conceptual framework was organized in to three dimensions (the intrapersonal dimension, the significant-other and context related dimension, the transcendental dimension). Initially 59 items were adopted. 2) These items were analyzed through the index of content validity(CVI) and 53 items were selected which met more than 80% on the CVI. 3) The pretest was carried out with 87 patients with cancer. After the pretest results were analyzed by item analysis, 44 items were selected. A second test of content validity was conducted and 6 items were eliminated considering the 80% CVI. 4) To test for reliability and validity, data collection was done during the period from January 25, 1999, to February 26, 1999. The subjects for the test were 160 patients with cancer and 185 healthy persons. analysis, item analysis and multitrait-multimethod method to analyze validity. The findings are as follows : 1) The Cronbach's alpha coefficient for internal consistency was .92 for the total 38 items and .79, .82, .85, for the three dimensions in that order. 2) The item analysis was based on the corrected item to total correlation coefficient( .30 or more) and information about the alpha estimate if this item was dropped from the scale. 3) As a result of the initial factor analysis using principal component analysis and varimax rotation, one item was deleted because of factor complexity (indiscriminate factor loadings). In the secondary factor analysis, 7 factors with eigenvalue of more than 1.0 were extracted and these factors explained 56 percents of the total variance. The seven factors were labeled as 'family relationship', 'emotional condition', 'physical discomfort', 'meaning and goal of life', 'contextual stimuli', 'change of body image', 'guilt feelings'. 4) The convergence effect between this instrument and the life satisfaction scale was identified and there was significant positive correlation(r= .52, p= .00). The discriminant validity between this instrument and the depression scale(CES-D) was tested and there was significant negative correlation(r= -.50, p= .00). The instrument for accessing the suffering of patients with cancer developed in this study was identified as a tool with a high degree of reliability and validity. In this sense, this tool can be effectively utilized for assessment in caring for patients with cancer.

  • PDF

양성 거대 세포종의 악성 변화 (Malignant Transformation of Benign Giant Cell Tumor)

  • 공창배;홍윤석;이광열;조상현;송원석;조완형;고재수;전대근
    • 대한골관절종양학회지
    • /
    • 제18권1호
    • /
    • pp.14-19
    • /
    • 2012
  • 목적: 저자들은 골육종으로 악성 변화한 거대 세포종 환자의 종양학적 결과에 대해 알아보고자 하였다. 대상 및 방법: 2000년 1월부터 2012년 2월까지 외부에서 양성 거대 세포종으로 진단받은 뒤 치료받고 재발한 후 악성 변화가 의심되어 본원으로 전원된 5명의 환자를 대상으로 하였다. 5명 환자 모두 방사선 치료를 시행받은 병력은 없었다. 결과: 모든 환자는 광범위 절제술 시행받았고, 술 후 조직병리 검사상 골육종으로 확진되었다. 원발성 병변은 원위 대퇴골 3명, 근위 대퇴골 1명, 원위 요골 1명이었다. 양성 거대 세포종으로 진단받고 악성 변화하기까지 기간은 평균 49.2개월(24-126개월)이었다. 평균 추시 기간은 21.6개월이었다. 본원에서 광범위 절제술을 시행 받았음에도 3명에서 원격 전이가 발생하였고, 이들 중 2명의 환자에서는 국소 재발도 확인되었다. 이들 3명 모두 사망하였다. 결론: 본 증례로 보아 적절한 치료를 받은 양성 거대 세포종 환자에서도 악성 변화는 5년 이내에 발생할 수 있다. 따라서, 정기적 추시 중 방사선학적으로 육종 변화가 의심되는 경우 보다 적극적인 치료가 필요하다고 생각된다.

자연 기흉의 임상적 고찰 -244례- (Clinical Evaluation of Spontaneous Pneumothorax -A Review of 244 Cases-)

  • 김병린
    • Journal of Chest Surgery
    • /
    • 제27권4호
    • /
    • pp.292-296
    • /
    • 1994
  • From March, 1985, to June, 1993, 244 patients with 345 episodes of spontaneous pneumothorax treated at Koryo General Hospital were reviewed. Most of the patients were male, and the ratio of male to female was 8:1. The average age of the patients with spontaneous pneumothorax was 32.8 years old. The site of pneumothorax was revealed left side in 53.3%, right side in 42.6%, and bilateral in 4.1%. The cause of pneumothorax were shown primary spontaneous pneumothorax in 73.4%, and secondary spontaneous pneumothorax in 26.6%. The underlying pathologic lesion in secondary spontaneous pneumothorax showed pulmonary tuberculosis in 56patients[86.1%], COPD in 4patients[6.2%], bronchial asthma in 2patients[3.1%], lung cancer in 2patients[3.1%], and pneumoconiosis in a patient[1.5%]. The usual clinical symptomes were dyspnea, chest pain and chest discomfort. Recurrence rate was as follow; 2nd episode 33.6%, 3rd episode in 26.8%, and above in 4th episode in 18.2%. All the patient of pneumothorax was treated as following; Closed thoracostomy tube drainage in 127patients, bullectomy in 88patients, lobectomy in 5patients, wedge resection in 2patients, conservative treatment with oxygen therapy in 21patients, and video assisted thoracoscopic bullectomy in a patient. The course of treatment of all of the patients were smooth and uneventful.

  • PDF

Influence of Culture Conditions on Production of NGPs by Aspergillus tubingensis

  • Lilia, Lopez De Leon;Isaura, Caceres;Julie, Bornot;Elodie, Choque;Jose, Raynal;Patricia, Taillandier;Florence, Mathieu
    • Journal of Microbiology and Biotechnology
    • /
    • 제29권9호
    • /
    • pp.1412-1423
    • /
    • 2019
  • The filamentous fungus Aspergillus tubingensis that belongs to the black Aspergillus section has the capacity to produce high-value metabolites, for instance, naphtho-gamma-pyrones (NGPs). For these fungal secondary metabolites, numerous biological properties of industrial interest have been demonstrated, such as antimicrobial, antioxidant and anti-cancer capacities. It has been observed that production of these secondary metabolites is linked with fungal sporulation. The aim of this research was to apply osmotic and oxidative environmental stresses to trigger the production of NGPs in liquid cultures with CYB (Czapek Dox Broth). In addition, numerous parameters were tested during the experiments, such as pH value, incubation time, container geometry, and static and agitation conditions. Results demonstrate that the produced amount of NGPs can be enhanced by decreasing the water activity ($a_w$) or by adding an oxidative stress factor. In conclusion, this study can contribute to our knowledge regarding A. tubingensis to present an effective method to increase NGP production, which may support the development of current industrial processes.

Reninoma: a rare cause of curable hypertension

  • Kim, Ji Hye;Kim, Ji Hyun;Cho, Myung Hyun;Park, Eujin;Hyun, Hye Sun;Ahn, Yo Han;Kang, Hee Gyung;Moon, Kyung Chul;Ha, Il-Soo;Cheong, Hae Il
    • Clinical and Experimental Pediatrics
    • /
    • 제62권4호
    • /
    • pp.144-147
    • /
    • 2019
  • The most common type of refractory hypertension found in children is secondary hypertension, which is a potentially curable disease. Reninoma, a renin-secreting juxtaglomerular cell tumor, is a rare cause of severe hypertension that is usually diagnosed in adolescents and young adults. Surgical resection of the tumor completely cures the hypertension of patients with reninoma. The typical clinical presentation of reninoma includes hypokalemia, metabolic alkalosis, and features secondary to the increased activation of the renin-angiotensin system without renal artery stenosis. We report a case of reninoma in a female adolescent with a typical clinical presentation, in which surgical removal of the tumor completely cured hypertension. We discuss here the clinical features, imaging studies, and immunohistochemical examination of the tumor used to establish the diagnosis of reninoma and for the management of the condition.

Elucidating molecular mechanisms of acquired resistance to BRAF inhibitors in melanoma using a microfluidic device and deep sequencing

  • Han, Jiyeon;Jung, Yeonjoo;Jun, Yukyung;Park, Sungsu;Lee, Sanghyuk
    • Genomics & Informatics
    • /
    • 제19권1호
    • /
    • pp.2.1-2.10
    • /
    • 2021
  • BRAF inhibitors (e.g., vemurafenib) are widely used to treat metastatic melanoma with the BRAF V600E mutation. The initial response is often dramatic, but treatment resistance leads to disease progression in the majority of cases. Although secondary mutations in the mitogen-activated protein kinase signaling pathway are known to be responsible for this phenomenon, the molecular mechanisms governing acquired resistance are not known in more than half of patients. Here we report a genome- and transcriptome-wide study investigating the molecular mechanisms of acquired resistance to BRAF inhibitors. A microfluidic chip with a concentration gradient of vemurafenib was utilized to rapidly obtain therapy-resistant clones from two melanoma cell lines with the BRAF V600E mutation (A375 and SK-MEL-28). Exome and transcriptome data were produced from 13 resistant clones and analyzed to identify secondary mutations and gene expression changes. Various mechanisms, including phenotype switching and metabolic reprogramming, have been determined to contribute to resistance development differently for each clone. The roles of microphthalmia-associated transcription factor, the master transcription factor in melanocyte differentiation/dedifferentiation, were highlighted in terms of phenotype switching. Our study provides an omics-based comprehensive overview of the molecular mechanisms governing acquired resistance to BRAF inhibitor therapy.

뼈 전이로 오인될 수 있는 흉강 외 악성 종양으로 인한 비대성 골관절증의 초기 영상 소견 (Early Imaging Findings of Hypertrophic Osteoarthropathy Mimicking Bone Metastasis from Extrathoracic Malignancy)

  • 황지연;차장규;윤유성;문아림
    • 대한영상의학회지
    • /
    • 제82권6호
    • /
    • pp.1606-1612
    • /
    • 2021
  • 비대성 골관절증은 곤봉지, 근막골형성 및 윤활막 삼출액을 특징으로 하는 증후군이다. 이차성 비대성 골관절증은 대부분의 경우 흉부 내 악성 종양과 연관이 있으나, 드물게 흉강 외 악성 종양에 의해 발생할 수 있다. 이에 우리는 유방암의 과거력이 있는 환자에서 발생한 비대성 골관절증의 초음파, 전산화단층촬영, 자기공명영상 및 뼈 신티그래피의 초기 영상의학적 소견에 대해 서술하고자 한다. 악성 종양으로 오인된 본 증례의 모호한 임상 및 영상 소견은 독자에게 흥미롭고 유익할 것으로 생각된다.

사망 원인별 유형 분석을 통한 사망자의 위생 관리에 대한 연구 (Study on Sanitary Management of Deceased Bodies through Categorical Analysis of Cause of Death)

  • 최정목
    • 한국콘텐츠학회논문지
    • /
    • 제17권7호
    • /
    • pp.265-275
    • /
    • 2017
  • 본 연구는 장례식장에서 사망자를 위생적으로 관리하기 위해 사망의 장소, 종류 및 원인 등 사망자들의 유형에 따라 체액 분출 등 사후 어떤 변화가 있는지 알아보고자 하였다. 사망자 858명을 대상으로 조사한 결과 평균 연령은 68.6세이며, 주요 사망의 원인은 83.0%가 병사이며, 사망 장소는 79.5%가 의료기관에서 발생되었다. 사망자에서 발생되는 체액 분출율은 전체 사망자의 46.2%에서 조사되었고, 사망의 종류에 따라서는 사고사가 78.8%로 가장 높고, 노화사는 10.8%로 가장 낮았다. 사망의 장소에 따른 의료기관 사망자는 46.3%, 주택 사망자는 38.6%인데 반해 기타 장소는 77.4%로 높았다. 사망의 원인으로 직접, 중간 및 선행 사인이 기록된 사망자 수는 크게 다르지만 체액 분출 비율은 비슷하였다. 장기 및 계통별 사망자 수는 직접, 중간 및 선행 사인 모두 호흡기질환과 심장질환 사망자 수가 가장 많고, 체액 분출은 직접 사인은 간질환 사망자가 가장 높고 소화기 및 혈액순환계 순이며, 중간 및 선행 사인에서는 기타 및 사고사가 가장 높은 비율을 보였다. 사망의 원인에 기록된 질병을 기준으로 한 사망자 수는 직접 사인은 심폐부전이 96명으로 가장 많고 폐렴 및 패혈증 순이며, 체액 분출은 사망자 수가 15명 이상 기준으로 담관암(73.3%)이 가장 높고, 췌장암, 중증뇌손상 및 간암 순으로 많았다. 따라서 사망자의 위생적 관리를 위해서는 보다 정확한 질병명과 발병기간을 명시하도록 하여야 하고, 사망자 이송과정에서는 관련 정보가 문서화 되고 체계적인 전달 시스템이 될 수 있도록 제도화 하여야 할 것이다.